0000950170-23-042625.txt : 20230815 0000950170-23-042625.hdr.sgml : 20230815 20230815072153 ACCESSION NUMBER: 0000950170-23-042625 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230810 ITEM INFORMATION: Other Events FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone bio, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 231173209 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Gritstone Oncology, Inc. DATE OF NAME CHANGE: 20151023 8-K 1 grts-20230810.htm 8-K 8-K
false000165663400016566342023-08-102023-08-10

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 10, 2023

 

 

Gritstone bio, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-38663

47-4859534

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

5959 Horton Street, Suite 300

 

Emeryville, California

 

94608

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 510 871-6100

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

GRTS

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

Item 8.01 Other Events.

On August 10, 2023, Gritstone bio, Inc. (the “Company”) entered into an Option and Nonexclusive License Agreement (the “License Agreement”) with Genevant Sciences GmbH (“Genevant”). Pursuant to the License Agreement and subject to the terms and conditions set forth in the License Agreement, Genevant granted the Company a multi-year option for nonexclusive license rights under certain intellectual property related to Genevant’s lipid nanoparticle technology to develop and commercialize self-amplifying RNA vaccines directed at select pathogens associated with infectious disease. Under the terms of the License Agreement, Genevant is eligible to receive from the Company option maintenance and exercise fees in the single digit millions, up to $136 million in contingent milestone payments per product, subject to increase for multi-pathogen products and in other specified circumstances, and royalties ranging from the mid to high single digits on future product sales. If the Company outlicenses an applicable infectious disease program, in lieu of certain of these payments, Genevant may be entitled to a percentage of amounts that Gritstone receives from its sublicensee.

The License Agreement is terminable by the Company for convenience with 90 days’ prior written notice or immediately if based on certain product safety or efficacy or regulatory criteria. Either party may terminate the License Agreement for material breach, subject to a cure period, and Genevant may, upon prior written notice and subject to the terms set forth in the License Agreement, terminate the License Agreement (i) if the Company challenges a licensed patent or (ii) only with regard to a certain pathogen, if the Company exploits other lipid nanoparticle technology with respect thereto.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Gritstone bio, Inc.

 

 

 

 

Date:

August 15, 2023

By:

/s/ Andrew Allen

 

 

 

Andrew Allen
President and Chief Executive Officer

 

 EX-101.PRE 2 grts-20230810_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 3 grts-20230810.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 grts-20230810_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Securities Act File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document And Entity Information
Aug. 10, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 10, 2023
Entity Registrant Name Gritstone bio, Inc.
Entity Central Index Key 0001656634
Entity Emerging Growth Company true
Securities Act File Number 001-38663
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 47-4859534
Entity Address, Address Line One 5959 Horton Street, Suite 300
Entity Address, City or Town Emeryville
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94608
City Area Code 510
Local Phone Number 871-6100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol GRTS
Security Exchange Name NASDAQ
XML 6 grts-20230810_htm.xml IDEA: XBRL DOCUMENT 0001656634 2023-08-10 2023-08-10 false 0001656634 8-K 2023-08-10 Gritstone bio, Inc. DE 001-38663 47-4859534 5959 Horton Street, Suite 300 Emeryville CA 94608 510 871-6100 false false false false Common Stock, $0.0001 par value per share GRTS NASDAQ true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports grts-20230810.htm grts-20230810.xsd grts-20230810_lab.xml grts-20230810_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "grts-20230810.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "grts-20230810.htm" ] }, "labelLink": { "local": [ "grts-20230810_lab.xml" ] }, "presentationLink": { "local": [ "grts-20230810_pre.xml" ] }, "schema": { "local": [ "grts-20230810.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "grts", "nsuri": "http://gritstonebio.com/20230810", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "grts-20230810.htm", "contextRef": "C_89180e5e-8a24-4c8f-8339-112052db5ed7", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "grts-20230810.htm", "contextRef": "C_89180e5e-8a24-4c8f-8339-112052db5ed7", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://gritstonebio.com/20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-042625-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-042625-xbrl.zip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end